Viewing Study NCT04377620


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-01 @ 6:27 AM
Study NCT ID: NCT04377620
Status: TERMINATED
Last Update Posted: 2022-01-19
First Post: 2020-05-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Sponsor: Incyte Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cytokine storm View
None COVID-19 View
None ARDS View
None SARS-CoV-2 View
None ruxolitinib View
None pneumonia View